CLINICAL STUDY: INTERVENTIONAL CARDIOLOGY
Coronary hemodynamics of stent implantation after suboptimal and optimal balloon angioplasty
Michiel Voskuil, MD*,
Rob A. M. van Liebergen, MD*,
Mariano Albertal, MD ,
Eric Boersma, PhD ,
Jan G. P. Tijssen, PhD*,
Patrick W. Serruys, MD ,
Jan J. Piek, MD*,* the DEBATE II Investigators
* Academic Medical Center, Amsterdam, The Netherlands
Thoraxcenter, Rotterdam, The Netherlands
* Reprint requests and correspondence: Dr. Jan J. Piek, Department of Cardiology, B2-108, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. j.j.piek{at}amc.uva.nl
OBJECTIVES: This study was performed to evaluate hemodynamic alterations of stent implantation after Doppler flowguided balloon angioplasty (BA).
BACKGROUND: There is controversy regarding the effect of stent implantation on coronary hemodynamics after suboptimal and optimal BA.
METHODS: A total of 523 of 620 patients underwent Doppler-guided BA in the setting of a multicenter study and were analyzed before and after additional stent implantation. Balloon angioplasty was considered optimal when the diameter stenosis (DS) was 35% and coronary flow reserve (CFR) was >2.5 and suboptimal if these two criteria were not met. Coronary flow reserve was also measured in an angiographically normal artery to determine relative CFR. Patients were followed for 12 months to document major adverse cardiac events (MACE).
RESULTS: The main difference between patients with suboptimal BA (n = 195 [51%]) and optimal BA (n = 184 [49%]) was a more pronounced increase in baseline blood flow velocity (15 ± 8 to 22 ± 11 vs. 14 ± 8 to 16 ± 10 cm/s, p < 0.01). Coronary flow reserve improved after stent implantation in both patient groups, owing to a reduction in residual lumen obstruction, as determined by angiographic (%DS) and Doppler flow criteria (hyperemic blood flow velocity, relative CFR), and was associated with a decrease in MACE (16% vs. 7% in optimal BA group, p = 0.08; and 27% vs. 11% in suboptimal BA group, p = 0.007).
CONCLUSIONS: Stent implantation enhances CFR after suboptimal and optimal Doppler-guided BA, owing to a reduction in residual lumen obstructiondetermined by angiographical and Doppler flow criteriaas the underlying mechanism for an improved clinical outcome.
|
Abbreviations and Acronyms
| | BA | | balloon angioplasty | | CFR | | coronary flow reserve | | DEBATE | | Doppler Endpoints Balloon Angioplasty Trial Europe | | DS | | diameter stenosis | | MACE | | major adverse cardiac events | | OR | | odds ratio | | PTCA | | percutaneous transluminal coronary angioplasty |
|
This article has been cited by other articles:

|
 |

|
 |
 
H. J. Verberne, M. Meuwissen, S. A. J. Chamuleau, B.-J. Verhoeff, B. L. F. van Eck-Smit, J. A. E. Spaan, J. J. Piek, and M. Siebes
Effect of simultaneous intracoronary guidewires on the predictive accuracy of functional parameters of coronary lesion severity
Am J Physiol Heart Circ Physiol,
May 1, 2007;
292(5):
H2349 - H2355.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Kern, A. Lerman, J.-W. Bech, B. De Bruyne, E. Eeckhout, W. F. Fearon, S. T. Higano, M. J. Lim, M. Meuwissen, J. J. Piek, et al.
Physiological Assessment of Coronary Artery Disease in the Cardiac Catheterization Laboratory: A Scientific Statement From the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology
Circulation,
September 19, 2006;
114(12):
1321 - 1341.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Siebes, B.-J. Verhoeff, M. Meuwissen, R. J. de Winter, J. A.E. Spaan, and J. J. Piek
Single-Wire Pressure and Flow Velocity Measurement to Quantify Coronary Stenosis Hemodynamics and Effects of Percutaneous Interventions
Circulation,
February 17, 2004;
109(6):
756 - 762.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Cox, G. W. Stone, C. L. Grines, T. Stuckey, D. J. Cohen, J. E. Tcheng, E. Garcia, G. Guagliumi, R. S. Iwaoka, M. Fahy, et al.
Outcomes of optimal or "stent-like"balloon angioplasty in acutemyocardial infarction: the CADILLAC trial
J. Am. Coll. Cardiol.,
September 17, 2003;
42(6):
971 - 977.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|